Kateri A. Ahrendt,Alexandre J. Buckmelter,Jonas Grina,Joshua D. Hansen,Ellen R. Laird,David Moreno,Brad Newhouse,Li Ren,Steven M. Wenglowsky,Bainian Feng,Janet Gunzner,Kim Malesky,Simon Mathieu,Joachi
申请号：
US12920045
公开号：
US08338452B2
申请日:
2009.02.27
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula (I) and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
